| 000 | 01973cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030724.0 | ||
| 008 | 121210s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.04.Ph.D.2012.Da.C | ||
| 100 | 0 | _aDalia Hamouda Elsadek Elsaid | |
| 245 | 1 | 4 |
_aThe correlation between hormone receptors, HER 2 and topoisomerase II and response to neoadjuvant chemotherapy in locally advanced breast cancer / _cDalia Hamouda Elsadek Elsaid ; Supervised Nasr M. Ali Ellahloby , Magda Mourad Elsayed , Fouad Mohamed AbouTaleb |
| 246 | 1 | 5 | _aالعلاقه بين وجود مستقبلات الهرمون و الهير٢ و التوبوايزوميراز٢ و الاستجابه للعلاج الكيماوى كعلاج أولى فى حالات سرطان الثدى المتقدم |
| 260 |
_aCairo : _bDalia Hamouda Elsadek Elsaid , _c2012 |
||
| 300 |
_a196 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Medical | ||
| 520 | _aTopoisomerase II-Ü is a molecular target of anthracyclines; several studies have suggested that topoisomerase II-Ü expression is related to response to anthracycline treatment. The objective of this study was to evaluate correlation between overexpression of Topo II-Ü, HER2-neu, and hormone receptors and response to primary anthracyclin-based chemotherapy in locally advanced breast cancer | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAnthracycline | |
| 653 | 4 | _aLocally advanced breast cancer | |
| 653 | 4 | _aTopoisomerase II-Ü | |
| 700 | 0 |
_aFouad Mohamed AbouTaleb , _eSupervisor |
|
| 700 | 0 |
_aMagda Mourad Elsayed , _eSupervisor |
|
| 700 | 0 |
_aNasr Mohamed Ali Ellahloby , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40559 _d40559 |
||